carcinomatous


Also found in: Dictionary, Thesaurus, Encyclopedia, Wikipedia.
Related to carcinomatous: carcinomatous myopathy, carcinomatous meningitis

carcinomatous

 [kahr″sĭ-no´mah-tus]
pertaining to or of the nature of cancer; malignant.

car·ci·nom·a·tous

(kar'si-nom'ă-tŭs),
Pertaining to or manifesting the characteristic properties of carcinoma.

carcinomatous

/car·ci·nom·a·tous/ (kahr″sĭ-nom´ah-tus) pertaining to or of the nature of cancer.

carcinomatous

[-om′ətəs]
pertaining to carcinoma. See also carcinous.

carcinomatous

adjective Referring to or characterised by carcinoma.

car·ci·no·ma·tous

(kahr'si-nō'mă-tŭs)
Pertaining to or manifesting the properties of carcinoma.

carcinomatous

pertaining to or of the nature of cancer; malignant.
References in periodicals archive ?
This model requires the malignant transformation of only a single cell line, which can then undergo clonal evolution and differentiation into a variety of carcinomatous and sarcomatous components.
An optical biopsy tool would also likely minimize the removal of unnecessary biopsies (eg, for inflammatory lesions) and allow mapping of carcinomatous areas to ensure complete resection, thereby streamlining and improving the throughput of surgical pathology work flow and, ultimately, optimizing patient care.
The ultrastructure and histogenesis of male germ neoplasia with emphasis on seminoma with early carcinomatous features.
Small cell carcinoma of the ureter with squamous cell and transitional cell carcinomatous components associated with ureteral stone.
Pleomorphic carcinoma is the appropriate diagnosis when carcinomatous elements are present with at least 10% of the tumor showing sarcomatoid differentiation (either spindled or giant cells).
Amatya et al (7) also reported an unusual case with a heterogenous carcinomatous component, including a basaloid squamous carcinoma as the major component and an invasive and in situ squamous cell carcinoma as a minor component, with the sarcomatous component showing rhabdomyoblastic differentiation.
It can be seen in normal prostatic epithelium, seminal vesicles, ejaculatory ducts, and even hyperplastic and carcinomatous glands.
55-58) When we analyzed the methylation status of 8 CIMP markers in CRCs with contiguous, conventional adenoma on the margin of the carcinoma lesion, no difference in the number of methylated genes was noted between the adenomatous and carcinomatous lesions, and the number of methylated genes was low (Figure 3).
Although cytokeratin AE1/AE3 expression in testicular seminomas has been proposed as a potential marker of early carcinomatous progression, (91) this concept has not been addressed in extragonadal sites.
For examples, cytokeratins are a reliable marker for carcinomatous differentiation but have limited utility for the other diagnostic goals; PAX2 and PAX8 can help identify almost all tumors with renal tubular differentiation but do not help with subtyping those tumors; the RCC marker is quite specific for clear cell or papillary RCC but expression can be focal and weak in high-grade tumors.
However, molecular evidence supports the concept that these are carcinomas of the lung, with a clonal origin from pluripotent stem cells, that are capable of divergent differentiation into various mixtures of carcinomatous and sarcomatous components.